Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endocannabinoid cerebrospinal fluid levels in migraine and its relation to symptoms of depression.

Cephalalgia : an international journal of headache·2026
Same author

From bench to bedside: relevant animal models across the migraine attack phases.

The journal of headache and pain·2026
Same author

Impact of cenobamate on cortical responses to transcranial magnetic stimulation in people with drug-resistant focal epilepsy.

Epilepsia open·2026
Same author

Visually-induced hemodynamic response and white matter hyperintensities in middle-aged women with ischemic stroke or migraine with aura.

Cephalalgia : an international journal of headache·2026
Same author

Indirect crosstalk between signalling pathways activated by CGRP and Piezo1 in human iPSC-derived endothelial cells relevant to migraine.

Cephalalgia : an international journal of headache·2025
Same author

Hippocampal and cortical activities reflect early hyperexcitability in an Alzheimer's mouse model.

Brain communications·2025

Related Experiment Video

Updated: Jul 2, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

Migraine and epilepsy: genetically linked?

Joost Haan1, Arn M J M van den Maagdenberg, Oebele F Brouwer

  • 1Department of Neurology K5Q, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands. jhaan@rijnland.nl

Expert Review of Neurotherapeutics
|September 2, 2008
PubMed
Summary
This summary is machine-generated.

Migraine and epilepsy may share common genetic roots, particularly involving ion transporter genes. Understanding this link could lead to new treatments for both neurological disorders.

More Related Videos

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

Related Experiment Videos

Last Updated: Jul 2, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

Area of Science:

  • Neurogenetics
  • Molecular Neurology

Background:

  • Familial hemiplegic migraine (FHM) research has identified three key genes (CACNA1A, ATP1A2, SCN1A), all related to ion transporters.
  • Mutations in these FHM genes are also linked to epilepsy, suggesting a potential shared genetic basis.
  • While many epilepsy genes exist, only SCN1A has been clearly associated with migraine, highlighting a gap in systematic research.

Purpose of the Study:

  • To explore the genetic relationship between migraine and epilepsy.
  • To investigate the role of ion transporter dysfunction in the pathophysiology of both conditions.
  • To identify potential targets for novel preventive treatments.

Main Methods:

  • Review of existing genetic studies on familial hemiplegic migraine and epilepsy.
  • Analysis of the known functions of FHM-associated genes (CACNA1A, ATP1A2, SCN1A).
  • Discussion of the implications of ion channel mutations on neuronal function and neurotransmitter release.

Main Results:

  • A significant overlap exists between genes associated with FHM and epilepsy, primarily ion transporter genes.
  • Dysfunction of ion transporters is proposed as a common underlying mechanism for both migraine and epilepsy.
  • Mutations in FHM genes can affect neuronal neurotransmitter release, a critical factor in both disorders.

Conclusions:

  • A genetic link between migraine and epilepsy is plausible, centered on ion transporter gene dysfunction.
  • Further research into this genetic relationship could illuminate the pathophysiology of both syndromes.
  • Identifying shared genetic mechanisms may pave the way for targeted preventive therapies for migraine and epilepsy.